Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Major facilitator superfamily domain-containing protein 8 (MFSD8) is a ubiquitous integral lysosomal membrane protein and putative secondary active transporter belonging to the atypical MFS transporter family.[1][2][5] Its physiological substrate is unknown. MFSD8 plays a role in membrane transport and endolysosomal chloride homeostasis, and is implicated in neuronal ceroid lipofuscinosis (variant late-infantile type, CLN7 disease), a severe neurodegenerative disorder presenting with developmental regression, seizures, ataxia, and vision loss.[2][3][7] MFSD8 is not currently known as a direct target of any therapeutic drugs and no pharmacological modulators have been identified to date.
Potential modulation of lysosomal transporter function or chloride conductance; precise mechanisms not established due to unknown physiological substrate
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major facilitator superfamily domain-containing protein 8 (MFSD8).